Apollo Hospitals files SEBI takeover disclosure under Regulation 31(4)
Apollo Hospitals submitted to NSE a Regulation 31(4) disclosure under the SEBI Takeover Regulations 2011. This is a mandatory notification when an acquirer breaches specified shareholding thresholds (typically 25% or 51%). The disclosure document filed on the NSE corporate actions portal is the primary evidence of the transaction announcement phase.
Why it mattersFiling of Regulation 31(4) disclosure indicates Apollo has crossed a materiality threshold in INDRAMEDCO shares; counsel must review the full disclosure statement for acquisition % and any conditions precedent to mandatory open offer trigger.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Actions Filing · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026